Olainfarm will supply anti-tuberculosis drugs to the WHO for more than 1 million dollars - P&T Community

-

Based on a cooperation agreement concluded last year, in the 1st quarter of 2019 JSC Olainfarm will be delivering its PAS- sodium anti-tuberculosis medicine, to the World Health Organisation (WHO) for a total of more than 1 million U.S. dollars. PAS-sodium is a widely known tuberculosis treatment drug that has proven its effectiveness globally, and the WHO is using it to treat tuberculosis in developing countries throughout Asia and Africa.
    
Oļegs Grigorjevs, Chairman of the Board, notes that cooperation with the WHO has been ongoing since 2011 when Olainfarm got qualified as a trusted WHO partner for the anti-tuberculosis programme; it has since regularly engaged in WHO procurement tenders.

“Global competition within this segment is extremely fierce, and we are glad to see that Olainfarm meets the most stringent WHO quality requirements for partners delivering these drugs; we are a proud long-standing partner for the anti-tuberculosis programme”, the head of JSC Olainfarm underscores. 

In 2011, the PAS-sodium drug produced by Olainfarm was included on the list of WHO qualified medicines and Olainfarm was the first pharmaceutical company in the Baltics to have a drug included in WHO programmes. Registration of the drug for WHO programmes in countries that face tuberculosis problems allows Olainfarm to sell this product as part of the programme without undergoing registration in each specific country – which opens doors to new sales markets.

Olainfarm has been producing PAS-sodium since 2001 and has been delivering it to specialized clinical centres in the Baltics and the international NGO Doctors without Borders (Médecins Sans Frontières) besides working with the World Health Organisation.

The first effective tuberculosis medicines were developed in the 1940s. In Western Europe and North America, cases of tuberculosis are very rare, but a large part of the world still has to deal with it every day. As evident from the WHO Global Tuberculosis Report 2018, there were about 10 million tuberculosis patients worldwide in 2017. 30 countries with the highest prevalence of tuberculosis accounted for 87% of all cases. Thanks to massive anti-tuberculosis initiatives implemented in the long term, the number of new diagnoses worldwide has been shrinking by an average of 2% annually; the 2020 target is to reduce the number of new cases by 4-5% every year.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in the production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries worldwide, including the Baltics, Russia, other CIS, Europe, Asia, North America, and Australia.

Information prepared by:

Dana Hasana
Head of Communication
JSC Olainfarm
dhasana@olainfarm.lv
+371 26355895



http://bit.ly/2ToA0yV

Comments

Post a Comment

Popular posts from this blog

Manual on meat inspection for developing countries

-
Image
sinusitis treatment :: Article Creator My 'sinus Infection' Turned Out To Be A One In A Million Nasal Cancer At Just 28 - And Doctors Had To Cut My Eye Out To Save Me By Emily Joshu Health Reporter For Dailymail.Com Published: 06:33 EDT, 20 April 2024Updated: 06:35 EDT, 20 April 2024 A 28 year-old California woman has described the shock of being diagnosed with a deadly sinus cancer that affects fewer than one in a million people - and led to the removal of her right eye. The 'golf ball-sized tumor', which had spread throughout her face, was first mistaken for a sinus infection by the woman's doctors.  Annika, who posts about her condition on TikTok, woke up one morning in 2023 and noticed that the inner corner of her right eye was sore.  While she at first thought nothing of it, by the time the evening rolled around, 'my face started to really, really hurt on the right side,' she said in a video.  The next day, her
Read more

Rash behind ear: Causes, other symptoms, and treatment - Medical News Today

-
Image
A rash behind the ear may occur due to a variety of different medical conditions. Certain viral infections and autoimmune diseases may cause a rash behind the ear in both children and adults. While some causes, such as contact dermatitis, are not concerning, other causes, including rubella, may be more serious. In this article, we look at some of the causes of a rash behind the ear, as well as the other symptoms that they may produce and how to treat them. Contact dermatitis is an allergic reaction to a particular substance. If an allergy-inducing substance comes into contact with the skin behind the ear, a rash can form. Allergens that may cause contact dermatitis behind the ears include: shampoos soaps other hair care products For example, hair dye products contain an ingredient called paraphenylenediamine (PPD), which is a common contact allergen. Symptoms Contact dermatitis causes itchiness, dryness, and flaking of the skin that came into contact with the allergen. Diagnosis A doc
Read more

Having This One Particular Blood Type Can Help Protect You From Severe Malaria - ScienceAlert

-
Image
Nearly  half the world's population is at risk of malaria, one of the most deadly diseases known to humankind. Each year it claims  over 400,000 lives, most of whom are children younger than age five. While it's possible to vaccinate against malaria, virtually all of these cases are in the African region, where protection is often nothing more than a roll of the dice. Now, a recent  analysis  of 23 papers suggests those with blood type O have the genetic odds stacked in their favour. In sub-Saharan Africa, where severe malaria - caused by the  Plasmodium falciparum  parasite  - is endemic, there are far more individuals with blood type O than anywhere in Europe or the US. In Nigeria alone, where 97 percent of the country is at risk of malaria, more than half the population belongs to this blood group. In Ethiopia and many others, the numbers are similar. Rather than a coincidence, co-author and epidemiologist Abraham Degarege Mengist from Robert Stempel College of Publi
Read more